Endocyte Inc. buy melinda
Start price
07.10.17
/
50%
€5.06
Target price
27.12.17
€5.41
Performance (%)
-21.03%
End price
27.12.17
€4.00
Summary
This prediction ended on 27.12.17 with a price of €4.00. The price of Endocyte Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.03%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Endocyte Inc. | - | - | - | - |
| iShares Core DAX® | -1.358% | -2.329% | 3.438% | 53.509% |
| iShares Nasdaq 100 | -3.700% | -1.242% | 33.079% | 90.966% |
| iShares Nikkei 225® | -2.512% | 6.914% | 60.778% | 81.100% |
| iShares S&P 500 | -1.662% | -0.643% | 23.467% | 67.066% |
Comments by melinda for this prediction
In the thread Endocyte Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
(Vom Mitglied beendet)